Cell-Penetrating Peptides: How Tiny Delivery Vehicles Are Being Used to Fight Cancer

This was a comprehensive literature review examining published research on cell-penetrating peptides in cancer drug delivery. The authors analyzed studies based on the amino acid composition and sequences of CPPs, with a focus on measurable changes in tumor volume in mouse models. They reviewed individual CPPs and their derivatives, covering approaches from natural protein sequence selection to computer-based design methods.

Cancer drugs often struggle to reach tumors effectively, and cell-penetrating peptides offer a promising solution by acting as molecular delivery vehicles. This review maps out what has worked so far and where the field is stuck, which is critical for directing future research toward approaches most likely to succeed in humans.

Cell-penetrating peptides sit at the intersection of peptide science and cancer drug delivery — two of the fastest-growing areas in pharmaceutical research. This review highlights a common pattern in peptide therapeutics: impressive results in animal models that face a 'bottleneck' when translating to human use. The findings underscore the need for better strategies to overcome biological barriers before CPP-based cancer treatments can reach patients.

This is a review article, not an original study, so it summarizes existing research rather than generating new data. The reviewed studies were predominantly conducted in mice, and animal results frequently don't translate to humans. The review does not provide a systematic meta-analysis or statistical pooling of results across studies, making it difficult to quantify overall effectiveness.